The Business Development and Licensing team at Dyadic International is responsible for identifying and pursuing strategic partnerships and licensing opportunities that enhance the company's C1 expression system. They work collaboratively with research and development to align business goals with innovative biotech solutions, aiming to accelerate the development and commercialization of biologic vaccines and drugs. Their efforts are focused on optimizing market access, improving patient outcomes, and driving revenue growth for the company.
View all